Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
#1PRI RANKED
Most Cited Paper
in Mosquito-borne diseases and control
18 Months Post-Publication
Class of 2026
“Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial”
A research intelligence initiative by Pepkio
pri.pepkio.com/top-papers/mosquito-borne-diseases-and-control/2026/
Topics
R21/Matrix-M · malaria vaccine · African children · phase 3 trial · Double-blind randomized placebo-controlled trial · vaccine efficacy · vaccine safety · Matrix-M adjuvant · Plasmodium falciparum · clinical malaria · seasonal malaria transmission · parasitaemia · vaccination schedule · booster dose · protective efficacy · adverse events · Immunogenicity · anti-circumsporozoite antibodies
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Mosquito-borne diseases and control Papers, Class of 2026. https://pri.pepkio.com/top-papers/mosquito-borne-diseases-and-control/2026. Accessed 2026-07-17. Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459